How does Sitagliptin compare to GLP-1 receptor agonists in managing blood glucose levels, and what are the pros and cons of each approach?
Sunil JoshiExplorer
How does Sitagliptin compare to GLP-1 receptor agonists in managing blood glucose?
Share
Sitagliptin, a DPP-4 inhibitor, increases GLP-1 levels subtly, aiding stable blood glucose control with minimal hypoglycemia risk and weight gain. GLP-1 receptor agonists have stronger effects, reducing glucose, promoting weight loss, but may cause gastrointestinal issues and are injectable.